<DOC>
	<DOCNO>NCT00162643</DOCNO>
	<brief_summary>Ritonavir boost protease inhibitor base therapy equivalent antiviral efficacy 48 week compare NNRTI base therapy patient antiretroviral therapy naïve initiate therapy CD4 count ≤ 200/mm3 .</brief_summary>
	<brief_title>PI Vs. NNRTI Based Therapy HIV Advanced Disease</brief_title>
	<detailed_description>Current guideline initial therapy HIV infection recommend 2 NRTIs plus either ritonavir boost protease inhibitor non-nucleoside reverse transcriptase inhibitor ( NNRTI ) . Recent data suggest rate response PI base therapy may slightly compromise baseline CD4 count ≤ 200/mm3 plasma HIV-1-RNA ≥ 100,000 copies/mL . This may equally apparent ritonavir boost protease inhibitor use . The effect baseline CD4 count HIV-1-RNA level antiviral efficacy NNRTI base regimens less well characterize . A significant number patient currently initiate therapy late stage progression , typically baseline CD4 count ≤ 200/mm3 . In Mexico approximately 60 % patient initiate therapy within range CD4 cell count . Currently , two combination recommend preferred two NRTIs either Efavirenz Lopinavir/ritonavir , combination PIs ritonavir consider alternative . Comparison : The efficacy ritonavir boost protease inhibitor base therapy versus NNRTI base therapy patient antiretroviral therapy naïve initiate therapy CD4 count ≤ 200/mm3 .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>HIV infected individual Men woman least 18 year old CD4+ T cell ≤200/ml Antiretroviral naive Suspected document active , untreated HIV 1 relate opportunistic infection ( OI ) condition require acute therapy ( e.g. , hepatitis C virus infection ) Platelet count &lt; 75,000 cells/mm3 . Hemoglobin &lt; 9 g/dL . AST and/or ALT great 5 time upper limit normal Documented suspect active tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiretroviral Therapy , Highly Active</keyword>
	<keyword>Protease Inhibitors</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
</DOC>